← Eichor
Condition: Pulmonary Hypertension Due To Left Heart Disease Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pulmonary Hypertension Due To Left Heart Disease

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.
Phase N/A · 1 location(s) · Hospital General Universitario Gregorio Marañon · NCT07537517
Pulmonary Hypertension Biorepository and Registry
Phase N/A · 1 location(s) · University of Kansas Medical Center · NCT04808596
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety
NA · 3 location(s) · Pulnovo Medical, Inc. · NCT07214376
Inhaled and Intravenous Milrinone in Patients With Severe Pulmonary Hypertension
Phase 4 · 1 location(s) · Zagazig University · NCT04484675
Hemodynamic Assessment of underLying myocyTe Function in Right Heart Failure
Phase N/A · 1 location(s) · Johns Hopkins University · NCT06299436
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.